MrHullMysterious
Well-Known Member
The reason is that oxford uses a harmless cold virus as its delivery method. If you get a full first dose, the immune system not only reacts to the protein spike from the payload, but also the cold virus. Thus 2nd dose the immune system attacks the delivery method too, making it less effective. (~60%)Not sure it'll be much more use than a flu jab - efficacy rates are way lower than Pfizer /Moderna. I'd be a lot happier if I saw more info on whether it prevents long Covid before getting excited about Oxford.
Those who accidentally got 1/2 first dose, the immune system didn't react as strong to the cold virus and so 2nd dose more effective (~90%)
This has been known for years and seen in tests with mice, so surprised why they are surprised ?

I suspect they will put forward the 1/2 + 1 dose to the regulators initially.
The biontech/moderna vaccines use a synthetic delivery method and so don't suffer this problem. But are more expensive & harder to store as a result.